Cargando…

Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?

Adult T cell leukemia/lymphoma (ATL) represents an ideal model for targeted therapy because of intrinsic chemo-resistance of ATL cells and the presence of two well identified targets: the HTLV-I retrovirus and the viral oncoprotein Tax. The combination of zidovudine (AZT) and interferon-alpha (IFN)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasr, Rihab, Hajj, Hiba El, Kfoury, Youmna, de Thé, Hugues, Hermine, Olivier, Bazarbachi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185778/ https://www.ncbi.nlm.nih.gov/pubmed/21994752 http://dx.doi.org/10.3390/v3060750

Ejemplares similares

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Animal models on HTLV-1 and related viruses: what did we learn?
por: Hajj, Hiba El, et al.
Publicado: (2012)

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2010)

Novel Treatments of Adult T Cell Leukemia Lymphoma
por: El Hajj, Hiba, et al.
Publicado: (2020)

Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma
por: Tsukasaki, Kunihiro, et al.
Publicado: (2020)

Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation
por: Shirinian, Margret, et al.
Publicado: (2013)

Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma
por: Marino-Merlo, Francesca, et al.
Publicado: (2018)

Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome
por: Kfoury, Youmna, et al.
Publicado: (2011)

Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2022)

Can we cure HTLV-I associated Adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2011)

Deciphering the molecular basis of arsenic/interferon-alpha induced eradication of leukemia initiating cells in adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2015)

ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2014)

Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival
por: Hleihel, Rita, et al.
Publicado: (2023)

Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells
por: El Hajj, Hiba, et al.
Publicado: (2021)

Hetero-cellular interaction between cancer cells and stem cells in cancer metastasis
por: El Saghir, Jamal, et al.
Publicado: (2011)

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” micro-environment in patients with adult T-cell leukemia lymphoma
por: Kchour, Ghada, et al.
Publicado: (2014)

Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia
por: Moodad, Sara, et al.
Publicado: (2018)

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma
por: Kchour, Ghada, et al.
Publicado: (2013)

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
por: Hamad, Ahmad, et al.
Publicado: (2013)

Arsenic trioxide (As(2)O(3)) as a maintenance therapy for adult T cell leukemia/lymphoma
por: Marçais, Ambroise, et al.
Publicado: (2020)

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment
por: Marçais, Ambroise, et al.
Publicado: (2012)

Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions
por: Lanza, Francesco, et al.
Publicado: (2021)

Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran
por: Hedayati-Moghaddam, Mohammad Reza, et al.
Publicado: (2022)

Target Therapy in Metastatic Pheochromocytoma: Current Perspectives and Controversies
por: Mohammed, Amrallah A., et al.
Publicado: (2014)

In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ
por: Akkouche, Abdou, et al.
Publicado: (2021)

Validation of a Drosophila model of wild-type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: an effective platform for treatment screening
por: Outa, Amani Al, et al.
Publicado: (2020)

Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1
por: Sibon, David, et al.
Publicado: (2015)

A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology
por: Skayneh, Hala, et al.
Publicado: (2019)

Toxoplasmosis: Current and Emerging Parasite Druggable Targets
por: Hajj, Rana El, et al.
Publicado: (2021)

A Pin1/PML/P53 axis activated by retinoic acid in NPM-1c acute myeloid leukemia
por: Hleihel, Rita, et al.
Publicado: (2021)

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma
por: Ramos, Juan C, et al.
Publicado: (2011)

Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1
por: Sibon, David, et al.
Publicado: (2015)

Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas
por: Kyriakidis, Ioannis, et al.
Publicado: (2022)

Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
por: Di Cosimo, Serena
Publicado: (2009)

Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas
por: Pilmis, Benoît, et al.
Publicado: (2023)

Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
por: Tobinai, Kensei, et al.
Publicado: (2012)

Cancer stem cell targeted therapy: progress amid controversies
por: Wang, Tao, et al.
Publicado: (2015)

Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells
por: Frazzi, Raffaele, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gfmtrjrcr1a37q270n4bugt65v